Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1991
10/19/1991WO1991017187A2 A 35kD TUMOR ASSOCIATED PROTEIN ANTIGEN: USES AND METHODS OF DETECTION
10/19/1991WO1991016432A1 Modified bacillus thuringiensis insecticidal-crystal protein genes and their expression in plant cells
10/19/1991WO1991016352A1 A method for the preparation of pyridoxylated hemoglobin
10/19/1991WO1991016078A1 Conjugate compounds containing aza-macrocycles, and processes for their preparation
10/19/1991CA2080835A1 A 35kd tumor associated protein antigen and immune complex
10/19/1991CA2079006A1 Method for the preparation of pyridoxylated hemoglobin
10/19/1991CA2058985A1 Conjugate compounds containing aza-macrocycles, and processes for their preparation
10/19/1991CA2040722A1 Monoclonal antibodies against pp4, processes for the preparation thereof and the use thereof
10/17/1991WO1991016348A1 Interleukin-4 binding protein-gamma
10/17/1991WO1991015773A1 A diagnostic test method
10/17/1991WO1991015771A1 Combinations of hepatitis c virus (hcv) antigens for use in immunoassays for anti-hcv antibodies
10/17/1991WO1991015770A1 Therapeutic uses of actin-binding compounds
10/17/1991WO1991015603A1 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof
10/17/1991WO1991015602A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
10/17/1991WO1991015596A1 Hepatitis c virus protease inhibitors
10/17/1991WO1991015589A1 Improved process of purifying recombinant proteins and compounds useful in such process
10/17/1991WO1991015587A1 Self-polymerising expression system based on modified potyvirus coat proteins
10/17/1991WO1991015586A1 Improvements relating to the detection of viruses
10/17/1991WO1991015585A1 Method for the protection of plants against pathogens
10/17/1991WO1991015584A1 Trypanosoma cruzi recombinant antigens and synthetic peptides for utilization in the immunological diagnosis of chagas disease
10/17/1991WO1991015583A1 A protein family related to immediate-early protein expressed by human endothelial cells during differentiation
10/17/1991WO1991015582A2 PURIFIED RAP GAPs, RAP GAP SEQUENCES, AND USES THEREOF
10/17/1991WO1991015581A1 Walk-through mutagenesis
10/17/1991WO1991015580A1 Gene therapy for cell proliferative diseases
10/17/1991WO1991015577A1 INTERLEUKIN 1 beta PROTEASE
10/17/1991WO1991015572A1 Live vaccines
10/17/1991WO1991015571A1 Expression of heterologous protein in yeast
10/17/1991WO1991015514A1 Oxidation resistant thrombomodulin analogs
10/17/1991WO1991015513A1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides
10/17/1991WO1991015511A1 Hybrid calcitonin
10/17/1991WO1991015509A1 Methods and formulations for stabilizing fibroblast growth factor
10/17/1991WO1991015508A1 Human splenopentine derivatives and process for producing them
10/17/1991WO1991015238A1 Methods and compositions for vaccination against hiv
10/17/1991WO1991015237A1 Compositions and treatments for pneumonia in animals
10/17/1991WO1991015236A1 Treatment of autoimmune diseases
10/17/1991WO1991015234A1 Recombinant bile salt activated lipases
10/17/1991WO1991015233A1 Use of protease nexin-i to mediate wound healing
10/17/1991WO1991015232A1 A cd43 fragment which binds to autoantibodies produced by hiv infected individuals
10/17/1991WO1991015231A1 Wound healing
10/17/1991WO1991015228A1 Method for the purification of epidermal growth factor
10/17/1991WO1991015227A1 Method and compositions for treating injury
10/17/1991WO1991015225A1 Multiple sclerosis t-cell receptor
10/17/1991WO1991015224A1 Inhibition of disease associated with immunodeficiency virus infection
10/17/1991WO1991015221A1 Inhibition of allograft and concordant xenograft rejection
10/17/1991WO1991015116A1 Doubly transgenic animals
10/17/1991WO1991013159A3 Regeneration and genetic transformation of sugar beet
10/17/1991WO1991012730A3 Recovery of protein, protein isolate and/or starch from cereal grains
10/17/1991WO1991008298A3 Fusion proteins consisting of a ligand binding protein and a stable plasma protein
10/17/1991WO1991006658A3 Infective protein delivery system
10/17/1991WO1991000916A3 Receptors for fibroblast growth factors
10/17/1991CA2080233A1 Hybrid calcitonin
10/17/1991CA2079903A1 Gene therapy for cell proliferative diseases
10/17/1991CA2079783A1 Use of protease nexin-i to mediate wound healing
10/17/1991CA2079600A1 Interleukin-4 binding protein-gamma
10/17/1991CA2078546A1 Methods and compositions for vaccination against hiv
10/17/1991CA2056439A1 Method for the protection of plants against pathogens
10/16/1991EP0452299A1 Method and composition for stimulating the growth of nerve processes
10/16/1991EP0452269A2 Tissue-preferential promoters
10/16/1991EP0452224A1 DNA molecule and plasmid containing at least one phage resistance mechanism, bacteria containing them and use therefor
10/16/1991EP0451957A2 Cyclohexapeptide compound
10/16/1991EP0451903A2 Composition for the regulation of hair growth
10/16/1991EP0451891A2 Peptides immunochemically reactive with antibodies directed against hepatitis Non-A, Non-B virus
10/16/1991EP0451878A1 Modifying plants by genetic engineering to combat or control insects
10/16/1991EP0451867A1 Parathyroid hormone antagonists
10/16/1991EP0451763A2 Peptide derivatives with amphiphatic properties, intermediates thereof and liposomes and films comprising said derivatives
10/16/1991EP0451700A1 Recombinant APP minigenes for expression in transgenic mice as models for Alzheimers's disease
10/16/1991EP0451550A2 Seroreactive epitopes of human Papillomavirus (HPV) 16 proteins
10/16/1991EP0451439A1 Use of a cartilage-inducing factor (CIF) for treating hematopoietic or lymphopoietic disorders
10/16/1991EP0451357A1 Pathogenesis factors of dermatophytes
10/16/1991EP0451244A1 Subtilisin mutants
10/16/1991EP0451211A1 Cloning and production of polypeptide analogs of human fibronectin and method of using such polypeptide analogs
10/16/1991EP0451206A1 Receptor transcription-repression activity compositions and methods
10/16/1991EP0451157A1 Transgenic animals for testing multidrug resistance
10/16/1991EP0434744A4 Serum immunoregulatory polypeptide and uses therefor
10/16/1991EP0423193A4 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human
10/16/1991EP0253845B1 Tangential flow affinity ultrafiltration
10/16/1991EP0193561B1 Monoclonal antibodies against metal chelates
10/16/1991CN1055389A Novel proteins with oncostatin m activity and process for their preparation
10/15/1991US5057603 Peptides having ANF activity
10/15/1991US5057496 Dipeptide compounds containing histidine or n-methyl histidine processes for their preparation and compositions containing them
10/15/1991US5057495 Atrial hypotensive peptide
10/15/1991US5057422 Recombinant dna: transformed microorganisms, plant cells and plants: a process for introducing an inducible property in plants, and a process for producing a polypeptide or protein by means of plants or plant cells
10/15/1991US5057417 Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein
10/15/1991US5057416 For polypeptide products
10/15/1991US5057411 For identifying specific viruses
10/15/1991US5057324 Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof
10/15/1991US5057302 Bifunctional chelating agents
10/15/1991US5057223 Purification of nerve growth factor (β subunit) by subunit exchange chromatography
10/15/1991US5057007 Low nox atmospheric gas burner
10/15/1991CA1290713C Protein and production thereof
10/15/1991CA1290688C Use of interleukin-1 to induce development of multipotent hemopoietic cell populations
10/14/1991WO1991016438A1 Dna molecule and plasmid comprising at least one phage resistant mechanism, bacteria containing same and uses thereof
10/14/1991CA2062736A1 Dna molecule and plasmid comprising at least one mechanism for resistance to phages, bacteria containing it, and their use
10/13/1991WO1991016632A1 Heat shock/stress response proteins and prognosis in cancer
10/13/1991WO1991016341A1 Peptide derivatives
10/13/1991CA2079345A1 Heat shock/stress response proteins and prognosis in cancer
10/13/1991CA2059302A1 Peptide derivatives
10/13/1991CA2040264A1 Parathyroid hormone antagonists
10/13/1991CA2040130A1 Composition for the regulation of hair growth
10/11/1991WO1991015507A1 Phosphonopeptides with collagenase inhibiting activity
1 ... 2753 2754 2755 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 ... 2916